m6A methylation in ferroptosis regulation: mechanisms, targets, and therapeutic interventions
Open Access
- 11 January 2026
- journal article
- review article
- Published by Elsevier in Journal of Advanced Research
- Vol. 88, 825-840
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (U22A20374)
This publication has 155 references indexed in Scilit:
- Neutrophil extracellular traps promote growth of lung adenocarcinoma by mediating the stability of m6A‐mediated SLC2A3 mRNA‐induced ferroptosis resistance and CD8(+) T cell inhibitionClinical and Translational Medicine, 2025
- The Correlation Analysis Between m6A Methylation Modification and Ferroptosis Induced by Cigarette Smoke in Human Bronchial EpitheliumImmunity, Inflammation and Disease, 2024
- The m6A modification of ACSL4 mRNA sensitized esophageal squamous cell carcinoma to irradiation via accelerating ferroptosisCell Biology International, 2024
- The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targetsClinical and Translational Medicine, 2024
- The IGF2BP3/Notch/Jag1 pathway: A key regulator of hepatic stellate cell ferroptosis in liver fibrosisClinical and Translational Medicine, 2024
- A Stapled Peptide Inhibitor Targeting the Binding Interface of N6‐Adenosine‐Methyltransferase Subunits METTL3 and METTL14 for Cancer TherapyAngewandte Chemie International Edition, 2024
- Glioblastoma and Other Primary Brain Malignancies in AdultsJAMA, 2023
- N6-methyladenosine writer METTL3 accelerates the sepsis-induced myocardial injury by regulating m6A-dependent ferroptosisApoptosis, 2023
- The N6‐methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastomaClinical and Translational Medicine, 2022
- Glutathione‐Bioimprinted Nanoparticles Targeting of N6‐methyladenosine FTO Demethylase as a Strategy against Leukemic Stem CellsSmall, 2022